INJECTION SITE EROSION

This adverse event was reported 352 times

These drugs are most commonly taken by patients reporting INJECTION SITE EROSION:

# Drug Count
0 BUPRENORPHINE 60
1 ETANERCEPT 36
2 TREPROSTINIL 28
3 GLATIRAMER ACETATE 23
4 ADALIMUMAB 22
5 FUROSEMIDE 19
6 BOSENTAN 16
7 INTERFERON BETA-1A 16
8 METFORMIN 16
9 METFORMIN ER 500 MG 16
See all common drugs associated with INJECTION SITE EROSION

INJECTION SITE EROSION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGVISOMANT 11 0.0027
1 RILONACEPT 2 0.0017
2 CAPLACIZUMAB 2 0.0011
3 HYALURONIC ACID 1 0.0009
4 INTERFERON BETA-1B 14 0.0007
5 TRIMETHOBENZAMIDE HYDROCHLORIDE 1 0.0007
6 BUPRENORPHINE 60 0.0006
7 TALIMOGENE LAHERPAREPVEC 1 0.0006
8 SENNOSIDES A AND B 1 0.0006
9 TAMSULOSIN HYDROCHLORIDE 12 0.0006
See all drugs enriched for association with INJECTION SITE EROSION